Poplar Therapeutics: Series A+

Open-source healthcare data infrastructure unifying patient records for clinicians

Develops oligonucleotide therapeutics targeting chronic hepatitis B

Uses AI and proteomics to discover drug targets and biomarkers for preeclampsia and eclampsia

AI platform automating medical coding and revenue assurance for health systems